Drug intelligence / Profile preview

Vilvadi Gulika

Development stage
Unknown
Lead developer
Arya Vaidya Sala Kottakkal
Administration
Oral
01

Overview

Vilvadi Gulika (also known as Vilvadi Gudika) is a traditional polyherbal Ayurvedic formulation manufactured by Kottakkal Arya Vaidya Sala. It is traditionally indicated for the treatment of infectious fevers, toxic conditions (such as insect and snake bites), and various digestive ailments. During the COVID-19 pandemic, the formulation was utilized for its potential immune-enhancing and anti-viral properties. Research conducted at the Centre for Medicinal Plants Research (CMPR) of Arya Vaidya Sala identified phytochemical constituents within the formulation that exhibit inhibitory activity against the SARS-CoV-2 virus. As a traditional Ayurvedic medicine, it functions through a holistic approach to immune support and detoxification rather than a single defined molecular mechanism. The formulation is administered orally in tablet form and is recognized in the U.S. National Institutes of Health's Public Health Emergency collections.

Brand names
Vilvadi Gulika
Other names
Vilvadi GudikaVilwadi Gulika

Beyond the preview

Go deeper on Vilvadi Gulika.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vilvadi Gulika.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call